7/19/2017
Stem cell ads: Promise much, deliver little
5/16/2017
Cashing in on emotions: How pharma profits from medicalizing the normal spectrum of feelings
5/11/2017
Why we should all be wary when PR machines promote phase 2 studies
4/3/2017
‘Fake breakthrough, fake news:’ One physician-researcher’s takeaway on news coverage of MS drug Ocrevus
3/16/2017
Strip mall stem cells
2/23/2017
MD Anderson Cancer Center’s IBM Watson project fails, and so did the journalism related to it
2/20/2017
‘Are YOUR lips attractive?’ Clickbait science fuels clickbait journalism
1/31/2017
One key detail you’re unlikely to see in news stories about mammography screening guidelines
1/27/2017
Tribune exposé on drug interactions reprises 20-year-old U.S. News report–highlights empty promises of pharmacy reform
1/4/2017
As health care costs spiral higher, hospital price increases are flying under the radar
